Note: Ingredients listed on restricted chemical lists
EC/CAS
7681-57-4
Name of the chemical
Sodium metabisulfite
Concentration
N/A
General Information
Revision date
2006-09-12
Product name
Sodium metabisulphite; part of "ECL Glycoprotein
Product Synonyms
Sodium metabisulphite; part of "ECL™ Glycoprotein
CAS No.
7681-57-4
supplier name
GE Healthcare UK Ltd
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Solid. Odor Sulfurous. OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview WARNING! CAUSES EYE IRRITATION. MAY CAUSE ALLERGIC RESPIRATORY AND SKIN REACTION. MAY BE HARMFUL IF SWALLOWED. MAY CAUSE RESPIRATORY TRACT AND SKIN IRRITATION. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE. May be harmful if swallowed. Severely irritating to eyes. Moderately irritating to the skin and respiratory system. May cause sensitization by inhalation and skin contact. Avoid exposure - obtain special instructions before use. Do not ingest. Do not get in eyes or on skin or clothing. Contains material that can cause target organ damage. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling.
Potential Acute Health Effects
Eyes Severely irritating to eyes. Risk of serious damage to eyes. Skin Moderately irritating to the skin. May cause sensitization by skin contact. Inhalation Moderately irritating to the respiratory system. May cause sensitization by inhalation. Ingestion Harmful if swallowed.
Potential chronic health
effects Contains material that can cause target organ damage. Once sensitized, a severe allergic reaction may occur when subsequently exposed to very low levels. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which may cause damage to the following organs: mucous membranes, upper respiratory tract, skin, eye, lens or cornea. Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing wheezing and breathing difficulties asthma Ingestion No specific data. Skin Adverse symptoms may include the following: irritation redness Eyes Adverse symptoms may include the following: pain or irritation watering redness
Medical Conditions Generally Aggravated by Exposure
Pre-existing respiratory and skin disorders and disorders involving any other target organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to this product. over-exposure See toxicological information (section 11)